<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">MESORIDAZINE BESYLATE</span><br/>(mez-oh-rid'a-zeen)<br/><span class="topboxtradename">Serentil<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">psychotherapeutic</span>; <span class="classification">phenothiazine</span>; <span class="classification">antipsychotic</span><br/><b>Prototype: </b>Chlorpromazine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg, 25 mg, 50 mg, 100 mg tablets; 25 mg/mL oral solution; 25 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Piperidine derivative of phenothiazine. Tranquilizer with stronger sedative action than produced by chlorpromazine, but has
         more antiemetic action and lower incidence of extrapyramidal adverse effects.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Antipsychotic effect due to psychomotor slowing and reduction of emotional stress.</p>
<h1><a name="uses">Uses</a></h1>
<p>Second-line therapy for schizophrenia, behavioral problems in mental deficiency and chronic brain syndrome, acute and chronic
         alcoholism. Also to reduce symptoms of anxiety and tension associated with many neurotic disorders.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Known sensitivity to other phenothiazines; severely depressed (drug-induced) patient; comatose state; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Previously detected cancer of breast; glaucoma; prostatic hypertrophy, urinary retention; history of cardiovascular disease
         (can prolong QTc interval).
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Psychotic Disorders</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1050 mg b.i.d. or t.i.d., may increase as needed up to 400 mg/d <span class="rdroute">IM</span> 25 mg, may repeat in 3060 min if necessary<br/><br/><span class="indicationtitle">Dementia Behavior</span><br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> 10 mg 12 times/d, may gradually increase q47d (max: 250 mg/d)<br/><br/><span class="indicationtitle">Management of Hyperactivity</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 25 mg t.i.d. up to 75300 mg/d<br/><br/><span class="indicationtitle">Alcohol Dependence</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 25 mg b.i.d. up to 50200 mg/d<br/><br/><span class="indicationtitle">Anxiety &amp; Tension</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 10 mg b.i.d. up to 150 mg/d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Measure drug with calibrated dispenser included in original package. Dilute oral concentrate in about ½ glass (120 mL) of
            fluid just before administration. Use fruit juices, water, soup, carbonated beverage.
         </li>
</ul><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Inject IM solution slowly and deeply into upper outer quadrant of buttock. Advise patient to lie still for 2030 min
            after the injection to minimize possible dizziness.
         </li>
<li>Slight yellowing of the solution will not change potency; however, darkened solution should be discarded.</li>
<li>Store at 15°30° C (59°86° F); refrigeration is not necessary. Protect solution from light
            and freezing.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Dizziness, <span class="speceff-common">sedation,</span> fainting, extrapyramidal effects, dystonic reactions, akathisia, tardive dyskinesia, <span class="speceff-life">neuroleptic malignant syndrome</span>. <span class="typehead">Special Senses:</span> Blurred vision, xerostomia, nasal congestion. <span class="typehead">Urogenital:</span> Urinary retention or incontinence, ejaculation dysfunction, impotence, priapism. <span class="typehead">GI:</span> Constipation. <span class="typehead">Body as a Whole:</span> Decreased sweating. <span class="typehead">Skin:</span> Rash, exfoliative dermatitis photosensitivity. <span class="typehead">CV:</span> Tachycardia, <span class="speceff-common">orthostatic hypotension,</span> arrhythmias (prolong QTc interval) heart block. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>
<b>Amiodarone,</b>
<b>amoxapine,</b>
<b>bepridil,</b>
<b>clarithromycin,</b>
<b>daunorubicin,</b>
<b>diltiazem,</b>
<b>disopyramide,</b>
<b>dofetilide,</b>
<b>dolasetron,</b>
<b>doxorubicin,</b>
<b>encainide,</b>
<b>erythromycin,</b>
<b>flecainide,</b>
<b>gatifloxacin,</b>
<b>grepafloxacin,</b>
<b>haloperidol,</b>
<b>ibutilide,</b>
<b>indapamide,</b>
<span class="classification">local anesthetics</span>, <b>maprotiline,</b>
<b>moxifloxacin,</b>
<b>octreotide,</b>
<b>pentamidine,</b>
<b>pimozide,</b>
<b>procainamide,</b>
<b>probucol,</b>
<b>quinidine,</b>
<b>risperidone,</b>
<b>sotalol,</b>
<b>sparfloxacin,</b>
<b>tocainide,</b>
<span class="classification">tricyclic antidepressants</span>, <b>verapamil,</b> and <b>ziprasidone</b> prolong the QTc interval and can cause arrhythmias; <b>amantadine,</b>
<b>clozapine,</b>
<b>cyclobenzaprine,</b>
<b>diphenoxylate,</b>
<b>olanzapine,</b>
<b>orphenadrine,</b>
<span class="classification">sedating h<sub>1</sub>-blockers</span> may have additive anticholinergic effects; <b>entacapone,</b>
<b>tolcapone,</b>
<b>pramipexole,</b>
<b>ropinirole</b>
<span class="classification">anticonvulsants</span> may cause additive drowsiness and CNS depressant effects. <span class="typehead">Herbal:</span>
<b>Kava-kava</b> may increase risk and severity of dystonic reactions. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 2 h PO; 30 min IM. <span class="typehead"> Duration:</span> 46 h PO; 68 h IM. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine and bile. <span class="typehead">Half-Life:</span> 2448 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor I&amp;O and bowel elimination patterns and check bladder for distension. Depressed patients often fail to report urinary
            discomfort or constipation.
         </li>
<li>Report to physician if patient complains of blurred vision. Periodic ophthalmic examinations are advisable with long-term
            therapy.
         </li>
<li>Monitor BP with patient supine and standing.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Avoid spilling drug on skin since it may cause contact dermatitis. Thoroughly rinse off with water if spilling occurs.</li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known. Dizziness and drowsiness are possible
            during early period of therapy.
         </li>
<li>Expect drowsiness to decrease with continued therapy. If it persists consult physician. A change in time of administration
            or dose may help to prevent interference with normal physical activities.
         </li>
<li>Dangle legs at bedside when rising because of possible orthostatic hypotension.</li>
<li>Avoid alcohol during therapy.</li>
<li>Relieve dry mouth by rinsing frequently with water, sucking hard candy.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>